Hello! Welcome to visit Readline 中文版 TEL:+86 0755-2665 9310

Contact Us

  • Contact:Jessie Huang +86 0755-2665 9310
  • Email[email protected]
  • Address:2-101,Bio-incubator, Gaoxin C.1st Ave.,Shenzhen Hi-tech Industrial Park,ShenZhen
Leader

    高管照片-劉建頭像2.jpeg

    Jian LiuFounder & Chairman of Readline Biology, Senior Engineer, Shenzhen "Local Leaders", Nanshan District "High-level Talents"In 2002, graduated from Lanzhou University majoring in chemistry. In 2013, graduated from Lanzhou University with a master's degree in MBA. From 2016 to 2017, Got a mid-career education from the applied psychology department of Tsinghua University. 2002-2017, worked in Shenzhen Xintai Fine Chemical Co., Ltd., Shenzhen hybio Co., Ltd. and Hybio Pharmaceutical Co., Ltd. (stock code: 300199), assistant researcher, researcher, senior fellow and director of research development, research development department manager, assistant president, subsidiaries and group vice President, general manager, during this period won several national, provincial, municipal and district-level awards. In 2017, as the initiator of Readline, committed to entrepreneurship and investment projects in the field of health field.

    高管照片-黃華03.jpeg

    Hua HuangDirector & Chief Scientist of Readline Biology, Researcher (professor), "Top talent" of South China Normal UniversityIn 2002, graduated from Lanzhou University majoring in chemistry. In 2011, graduated from the department of enzymology, the University of New Mexico with a doctor's degree. From 2002 to 2005, worked as a pharmaceutical synthetic researcher in Basilea Pharmaceutica (China) Ltd. Since 2011, successively in the University of New Mexico, the University of Illinois at Urbana Champaign, South China Normal University to carry outthe enlarge of enzyme catalysis, protein engineering and synthetic biology, genome enzymology andscientific research work in the field of microbiology and so on. During the study and scientific research work, 6 articles have been published and won the title of "top talent" of South China Normal University. In 2017, as the founder of Readline Biology, focus on the application of immobilized enzyme technology.

    高管介紹-張新帥.jpg

    Xinshuai ZhangChief Scientist of Readline Biology, Researcher of South China Normal UniversityGraduated from the University of New Mexico in 2012 with a PhD in Chemistry.She engaged in postdoctoral research in the field of genomic enzymology and microbiology at the Institute of Genomic Biology, University of Illinois, Champaign, USA from 2012 to 2019.In March 2019, she was introduced to the College of Life Sciences of South China Normal University as a young top-notch talent and engage in independent scientific research. In 2017, she joined Readline Biology as chief scientist, devoted herself to the application of immobilized enzyme technology.

    高管照片-何平.jpeg

    Roy HeDirector & CEO of Readline BiologyIn 1999, graduated from Sichuan University majoring in applied chemistry. 1999-2002, worked in Chongqing Daxin Pharmaceutical Co., Ltd., and was engaged in quality research and analytical method development. 2002-2019, he joined Hybio Pharmaceutical Co., Ltd. (stock code:300199), and engaged in research and development of polypeptide drugs, large-scale production and planning and construction of production base of Wuhan subsidiary company. He has successively been a technician of R&D center, Minister of purification, deputy director of the center, production director and deputy general manager. During this period, he has participated in many major new drug creation projects and won patents and Shenzhen innovation awards. Joined Readline in February 2019.

    高管照片-何遂平01.jpg

    Suiping HeDirector of Readline BiologyIn 2001, graduated from Southwest University in pharmaceutical engineering. 2002-2017, worked in Shenzhen Agilent Medical Equipment Co., Ltd., Shenzhen MINDRAY Bio Medical Electronic Limited by Share Ltd(Stock code:300760), Shenzhen blue rhyme Industrial Co., Ltd. and Old Ken medical Polytron Technologies Inc, as sales commissioner, the sales manager, product manager, marketing manager, regional marketing manager, marketing director and so on. In 2017, as the founder of Readline Biology, focus on the application of immobilized enzyme technology.

    Junfeng PanDirector & CMO of Readline Biology, Senior Engineer, Shenzhen "Local Leaders", Nanshan District "High-level Talents"In 2002, graduated from Lanzhou University majoring in chemistry. 2002-2017, worked in Shenzhen Xintai Fine Chemical Co., Ltd. and Hybio Pharmaceutical Co., Ltd. (stock code:300199), as assistant researcher,researcher, senior researcher, subsidiary, deputy general manager and director of operations group strategy, in the meantime won several national, provincial, municipal and district-level awards. Joined Readline in Feberary 2018.

    高管照片-王俊梅.jpeg

    Junmei WangCFO of Readline BiologyIn 2005, graduated from Xi'an Jiaotong University with a master's degree in management. From 2006 to 2018, worked in Huawei Technology Co., Ltd, successively served as financial manager, senior financial manager, national CFO, senior financial manager, financial expert and other positions, and participated in profit evaluation and risk control of many major and complex projects.Joined in Readline In September 2018.    

    高管照片-于倩.jpeg

    Qian YuR&D Manager of Readline BiologyIn 2006, graduated from Northwest University of Agriculture and Forestry with a bachelor degree in food science and engineering. In 2009, she graduated from South China University of Technology with a master's degree in food science. Since 2009, she worked in R&D center of Boton Group (stock code:3318.HK) and Shenzhen Gutesheng Biotechnology Co., Ltd. successively as R&D engineer, R&D director and R&D manager. Joined Readline in February 2018.  

    Lijing FangConsultant of Readline Biology, Research Associate, Shenzhen "Overseas high-level talents", Nanshan District "High-level Talents"In 2002, graduated from Lanzhou University majoring in chemistry. In 2007, graduated from Lanzhou University majoring in chemistry as a doctoral candidate.  From 2007 to 2010, Texas A&M University conducted postdoctoral research. Since 2010, successively in Dow Chemical (China) Co., Ltd., Shenzhen Advanced Technology Research Institute, Chinese Academy of Sciences Institute of Biomedicine and Technology, Institute of Medicine and Technology, as senior researcher, assistant researcher, associate researcher. In 2018, joined Readline Biology as a scientific consultant, focus on the application of immobilized enzyme technology.

    Xing HuoConsultant of Readline Biology, Associate ProfessorIn 2002, graduated from Lanzhou University majoring in chemistry. In 2008, graduated from Lanzhou University majoring in chemistry as a doctoral candidate. 2008 to 2009, studied inEast China University of Science and Technology of science and technology-advanced. 2014-2015, as a visiting scholar at Scripps research institute in San Diego, California. Since 2008, teach in theChemistry and Chemical Engineering of Lanzhou University. In 2017, joined Readline Biology as a scientific consultant, focus on the application of immobilized enzyme technology.

    周志軍照片-官網.jpg

    Zhijun ZhouConsultant of Readline Biology, Researcher of Southwest Medical University, Expert of Sichuan Thousand talents plan and Science and Technology Expert Bank of ChinaGraduated from Lanzhou University in 2001. From 2001 to 2006, he took office in Shanghai Institute of Organics, Chinese Academy of Sciences and Kant Yao Ming. In 2007, he received a doctorate in Chemistry from the University of New Mexico, USA. From 2010 to 2012, he was engaged in postdoctoral research at Washington University and Nanyang Polytechnic University, respectively. Since 2012, he has worked as a researcher at the Chinese Academy of Engineering Physics and Southwest Medical University, respectively. He has been engaged in the research of targeted radiopharmaceuticals and antimicrobial mimetic peptide drugs for a long time. In 2019, he joined Readline Biology as a scientific consultant and devoted himself to the application of new polypeptide technologies.

    高管照片-張慧鋒.jpeg

    Ben ZhangCEO of Readline TechnologyIn 2001, graduated from Lanzhou University in Computer Science. 2001-2008, he engaged in enterprise ERP and information technology. He served Acer China and Evinsoft. He was successive development engineer, system architect, product consultant and product technology director. Since 2009, he engaged in the Internet + industry, serving the alibaba (stock code:BABA; Internet + small commodity wholesale), SF-express (stock code:002352; Internet + Industrial Park), and Noposion ttyun (stock code:002215; Internet + agriculture services). He has been a product expert, product director and deputy general manager. Join Redline in February 2019.  

甘肃快3走走势图